In preclinical oncology, researchers face a familiar tension: how to capture reliable, longitudinal tumor data without relying on invasive procedures like biopsies or euthanasia.  These traditional methods often require larger animal cohorts, introduce variability, and provide only single-time-point insights, limiting understanding of tumor progression (Goyal et al., 2018). The new SkinScanner, a...